Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

BRISTOL MYERS SQUIBB

  • FDA Approval
  • Jan. 22, 2024, 09:56 UTC
  • 38
  • 0 comments

FDA approve ABATACEPT

Comment Full text

JANSSEN BIOTECH

  • FDA Approval
  • Jan. 22, 2024, 09:56 UTC
  • 36
  • 0 comments

FDA approve ERDAFITINIB

Comment Full text

GRANULES

  • FDA Approval
  • Jan. 22, 2024, 09:56 UTC
  • 36
  • 0 comments

FDA approve ACETAMINOPHEN

Comment Full text

KERYX BIOPHARMS

  • FDA Approval
  • Jan. 22, 2024, 09:56 UTC
  • 38
  • 0 comments

FDA approve FERRIC CITRATE

Comment Full text

BIONPHARMA

  • FDA Approval
  • Jan. 22, 2024, 09:56 UTC
  • 36
  • 0 comments

FDA approve TERAZOSIN HYDROCHLORIDE

Comment Full text

QUAGEN

  • FDA Approval
  • Jan. 22, 2024, 09:56 UTC
  • 37
  • 0 comments

FDA approve ACETAMINOPHEN; BUTALBITAL; CAFFEINE

Comment Full text

SANDOZ INC

  • FDA Approval
  • Jan. 22, 2024, 09:56 UTC
  • 36
  • 0 comments

FDA approve FILGRASTIM-SNDZ

Comment Full text

QUAGEN

  • FDA Approval
  • Jan. 22, 2024, 09:56 UTC
  • 32
  • 0 comments

FDA approve ACETAMINOPHEN; BUTALBITAL

Comment Full text

RECORDATI RARE

  • FDA Approval
  • Jan. 22, 2024, 09:56 UTC
  • 31
  • 0 comments

FDA approve CARGLUMIC ACID

Comment Full text

NOVITIUM PHARMA

  • FDA Approval
  • Jan. 22, 2024, 09:56 UTC
  • 37
  • 0 comments

FDA approve PAROXETINE HYDROCHLORIDE

Comment Full text
  • Previous
  • 569
  • 570
  • 571
  • 572
  • 573
  • Next

Search

News categories

  • Technical Exchange News(13116)
  • Event(6229)
  • SEC News(328522)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(183614)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin